Concord Corp.'s trial balance at December 31, 2023 is properly adjusted except for the income tax expense adjustment. Concord Corp. Trial Balance December 31, 2023 Dr. Cr. Cash $338000 Accounts receivable (net) 1447700 Inventory 1193100 Property, plant, and equipment (net) 4184900 Accounts payable and accrued liabilities $992600 Income tax payable 345000 Future tax liability 37200 Common shares 1676600 Contributed surplus 1340900 2323300 Retained earnings, Jan. 1, 2023 Not cales and other revenues 6180600 Net sales and other revenues 6180600 Costs and expenses 5042600 Income tax expenses 689900 $12896200 $12896200 Other financial data for the year ended December 31, 2023: Included in accounts receivable is $361600 due from a customer and payable in quarterly instalments of $45200. The last payment is due December 29, 2025. The balance in the future income tax liability account relates to a temporary difference that arose in a prior year, of which $16700 is classified as a current liability. During the year, estimated tax payments of $331500 were charged to income tax expense. The current and future tax rate on all types of income is 35 percent. In Concord's December 31, 2023 statement of financial position, the current assets total is $2798000. $2240500. $1604900. $2978800.